Skip to content

AOCI at other companies

Merck & Co. logo
Merck & Co.MRK
-$4.06B+18.2%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$11.9M-59.1%
Theravance Biopharma logo
Theravance BiopharmaTBPH
-$62K
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$0+100%
MeiraGTx Holdings plc logo
MeiraGTx Holdings plcMGTX
$2.58M+151%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
-$558K-328%

Other financials

Income statement

See full
Revenue$696.0K-97.2%
Gross profit$9.8M-30.1%
Operating income-$87.2M-78.6%
Net income-$84.8M-87.7%
EPS (diluted)-$0.99-52.3%

Balance sheet

See full
Cash & equivalents$77.7M-8.7%
Total debt$22.3M-7.3%
Total equity$230.5M-22.8%
Total assets$288.2M-20.5%

Cash flow

See full
Operating cash flow-$80.5M-51.6%
CapEx$997.0K+261%
Free cash flow-$81.5M-52.7%

Valuation

See full
Market cap$1.21B+108%
Enterprise value$1.15B+122%
P/S158.5×+148×

Profitability

See full
Operating margin-3,700.9%-4,042pp
Net margin-3,566.6%-3,874pp
FCF margin-3,565.9%-3,884pp

Returns & leverage

See full
Return on equity-102.7%+1,157pp
Debt / equity0.1×0.0×
Current ratio6.7×-1.2×

Where this comes from

Reported directly by EyePoint, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: EyePoint, Inc. ’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about EyePoint, Inc. 's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is EyePoint, Inc. 's AOCI?
EyePoint, Inc. (EYPT) reported AOCI of $802K in Q1 2026.
How has EyePoint, Inc. 's AOCI changed year-over-year?
EyePoint, Inc. 's AOCI decreased by 13.1% year-over-year, from $923K to $802K.
What is the long-term trend for EyePoint, Inc. 's AOCI?
Over 5 years (2020 to 2025), EyePoint, Inc. 's AOCI has grown at a 2.7% compound annual growth rate (CAGR), from $841K to $961K.
What does AOCI mean?
Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.